Cargando…
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Yellow Oil in Healthy Participants
Due to a lack of published pharmacokinetic (PK) and/or pharmacodynamic (PD) data, decision-making surrounding appropriate dosing of cannabis used for medical purposes is limited. This multiple-dose study evaluated the safety, tolerability, PK and PD of Spectrum Yellow oil [20 mg/mL cannabidiol (CBD)...
Autores principales: | Peters, Erica N, Mosesova, Irina, MacNair, Laura, Vandrey, Ryan, Land, M Hunter, Ware, Mark A, Turcotte, Cynthia, Bonn-Miller, Marcel O |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021973/ https://www.ncbi.nlm.nih.gov/pubmed/33710277 http://dx.doi.org/10.1093/jat/bkab026 |
Ejemplares similares
-
Safety, Pharmacokinetics and Pharmacodynamics of Spectrum Red Softgels in Healthy Participants
por: Peters, Erica N, et al.
Publicado: (2021) -
Pharmacokinetics of cannabichromene in a medical cannabis product also containing cannabidiol and Δ(9)-tetrahydrocannabinol: a pilot study
por: Peters, Erica N., et al.
Publicado: (2021) -
Effect of Cannabidiol on the Long-Term Toxicity and Lifespan in the Preclinical Model Caenorhabditis elegans
por: Land, M. Hunter, et al.
Publicado: (2021) -
Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants
por: Perera, Vidya, et al.
Publicado: (2022) -
Determination of Pharmacokinetic and Pharmacokinetic-Pharmacodynamic Parameters of Doxycycline against Edwardsiella ictaluri in Yellow Catfish (Pelteobagrus fulvidraco)
por: Xu, Ning, et al.
Publicado: (2021)